The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 169 Tissue Microarray - LS-SCA169

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA169
Product Name:	General Cancer Screen 169
Description:	6 common types of cancer with stage/grade and matched normal/non-neoplastic specimens
Format:	FFPE
Category:	Human Multi-Tumor and Normal
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Cases:	58
Cores:	66
Slides Per Set:	1

LS-SCA169 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10	11
A	Pla	Unk	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Col	Col	Col	Col	Col	Col	Col	Col	Col	Col	Col
C	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid
D	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
E	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto
F	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Bladder (Bla); Colon (Col); Kidney (Kid); Lung (Lng); Placenta (Pla); Stomach (Sto); Unknown (Unk); Uterus (Ute); Uterus, Endometrium (Ute);

LS-SCA169 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Differentiation	Tumor Size	Tumor Grade
1	A1	Human	F	28 y	Placenta (Pla)	Normal	Benign non-neoplastic
1	A2	Human	U		Unknown (Unk)	Normal	Benign non-neoplastic
1	A3	Human	M	67 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T3N0M0	Moderately	8X7 cm
1	A4	Human	M	35 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		Moderately
1	A5	Human	M	77 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T2N0M0		3x3x1.5 cm	Grade I
1	A6	Human	M	69 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T3N0M0	Moderately	8x8x1.5 cm
1	A7	Human	M	75 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0		6x5x2.5 cm	Grade III
1	A8	Human	F	58 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0		4x4xx2.5 cm	Grade II
1	A9	Human	F	58 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	A10	Human	M	37 y	Bladder (Bla)	Transitional cell carcinoma	Malignant				Grade II-III
1	A11	Human	M	37 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	B1	Human	M	68 y	Colon (Col)	Adenocarcinoma, Ulcer	Malignant	T3N2M0	Moderately	5x4x2 cm
1	B2	Human	M	75 y	Colon (Col)	Adenocarcinoma	Malignant	TxN2M1	Moderately
1	B3	Human	M	54 y	Colon (Col)	Adenocarcinoma	Malignant	T3N1M0	Moderately	5x4x4 cm
1	B4	Human	M	65 y	Colon (Col)	Adenocarcinoma	Malignant	T2N0M1	Poorly	3x2.5x1.2 cm
1	B5	Human	M	61 y	Colon (Col)	Adenocarcinoma	Malignant	T3N2M1	Moderately-Well	6x4x2.5 cm
1	B6	Human	F	42 y	Colon (Col)	Adenocarcinoma	Malignant	T2N0M0	Well	4x3.5x3.5 cm
1	B7	Human	F	54 y	Colon (Col)	Adenocarcinoma	Malignant	T2N2M0	Moderately	4x3x3 cm
1	B8	Human	F	52 y	Colon (Col)	Adenocarcinoma	Malignant	T3N0M0	Moderately	5x4x3 cm
1	B9	Human	F	53 y	Colon (Col)	Adjacent normal	Benign non-neoplastic
1	B10	Human	F	41 y	Colon (Col)	Squamous cell carcinoma	Malignant	T2N0M0	Moderately	4x3.5x2.5 cm
1	B11	Human	F	40 y	Colon (Col)	Adjacent normal	Benign non-neoplastic
1	C1	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N1M0	Moderately	3.5x3x3 cm
1	C2	Human	F	46 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Well	7x5.5x5.5 cm
1	C3	Human	M	58 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Moderately	8x6.3 cm
1	C4	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N2M0	Well	3.5X3.5X3.2 cm
1	C5	Human	M	54 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	4x3.5x3 cm
1	C6	Human	M	54 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	3x3x2.5 cm
1	C7	Human	M	68 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	4.5x4x4 cm
1	C8	Human	M	70 y	Kidney (Kid)	Granular cell carcinoma	Malignant	T3N0M0		7x6x5 cm
1	C9	Human	M	70 y	Kidney (Kid)	Adjacent normal	Benign non-neoplastic
1	C10	Human	M	33 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	2.5x2x2 cm
1	C11	Human	M	33 y	Kidney (Kid)	Adjacent normal	Benign non-neoplastic
1	D1	Human	M	89 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	Poorly-Moderately	3x3x2.5 cm
1	D2	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N4M1	Poorly	3.3x3x2.5 cm
1	D3	Human	M	58 y	Lung (Lng)	Adenocarcinoma	Malignant	T3N0M0	Moderately-Well	5x4x3 cm
1	D4	Human	M	64 y	Lung (Lng)	Adenocarcinoma with bronchioloalveolar carcinoma	Malignant	T2N2M0	Moderately	2x2x1 cm
1	D5	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N4M0	Moderately	3.7x3x3 cm
1	D6	Human	M	54 y	Lung (Lng)	Adenocarcinoma with squamous cell carcinoma	Malignant	T2N2M1	Moderately	2.5x2x1 cm
1	D7	Human	M	54 y	Lung (Lng)	Bronchioalveolar carcinoma	Malignant	T2N0M0		4x3x3 cm
1	D8	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	Poorly	5X4X4 cm
1	D9	Human	M	72 y	Lung (Lng)	Adjacent normal	Benign non-neoplastic
1	D10	Human	M	63 y	Lung (Lng)	Bronchioalveolar carcinoma	Malignant	T3N4M1		7X5X5 cm
1	D11	Human	M	63 y	Lung (Lng)	Adjacent normal	Benign non-neoplastic
1	E1	Human	M	50 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Poorly-Moderately	4.5x3.5x1.5 cm
1	E2	Human	M	69 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Moderately	4.5x4x2.5 cm
1	E3	Human	M	58 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Moderately	4.7x4x2.1 cm
1	E4	Human	M	47 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N2M0	Moderately	6x5x3 cm
1	E5	Human	F	42 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Moderately	4.2x4x2.2 cm
1	E6	Human	M	40 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Moderately	3.6x3.5x2 cm
1	E7	Human	M	48 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N2M1	Poorly	6x5x2 cm
1	E8	Human	F	55 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Moderately	4x3x1.5 cm
1	E9	Human	F	55 y	Stomach (Sto)	Adjacent normal	Benign non-neoplastic
1	E10	Human	M	59 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N4M1	Moderately-Well	6x4.5x1.5 cm
1	E11	Human	M	59 y	Stomach (Sto)	Adjacent normal	Benign non-neoplastic
1	F1	Human	F	46 y	Uterus, Endometrium (Ute)	Endometrial adenocarcinoma	Malignant	T3N0M0		6x5x4 cm
1	F2	Human	F	49 y	Uterus, Endometrium (Ute)	Endometrial adenocarcinoma	Malignant	T3N0M0	Moderately	10x8x1.5 cm
1	F3	Human	F	25 y	Uterus (Ute)	Squamous cell carcinoma	Malignant	T3N0M0	Poorly	5x2.5 cm
1	F4	Human	F	36 y	Uterus (Ute)	Adenomyoma	Tumor	T3N0M0		Diameter 7.5 cm
1	F5	Human	F	42 y	Uterus (Ute)	Adenoma	Tumor	T2N2M0		Diameter 4.0 cm
1	F6	Human	F	66 y	Uterus, Endometrium (Ute)	Endometrial adenocarcinoma	Malignant	T2N2M0	Well	3x0.4x0.2 cm
1	F7	Human	F	35 y	Uterus, Endometrium (Ute)	Endometrial adenocarcinoma	Malignant	T2N2M0	Well	1x2.5 cm
1	F8	Human	F	50 y	Uterus (Ute)	Leiomyoma	Tumor	T2N2M0		3x2x2 cm
1	F9	Human	F	50 y	Uterus (Ute)	Adjacent normal	Benign non-neoplastic
1	F10	Human	F	37 y	Uterus (Ute)	Leiomyoma, Multiple	Tumor
1	F11	Human	F	37 y	Uterus (Ute)	Adjacent normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.